Finetriax-T 500 contains combination of Ceftriaxone and Tazobactum. This combination exhibits a synergy that is not influenced by the presence or absence of oxygen. In addition, this synergy remains excellent at neutral pH. Finetriax-T has excellent anti-bacterial activity. It is indicated in Urinary tract infections, Lower respiratory tract infections, Acute sinusitis, Skin and skin structure infections, Bone and Joint infections, Intra-abdominal infections and Meningitis.
ANTI-BIOTICS / ANTI-BACTERIAL
Ceftriaxone 500 mg. & Tazobactam 62.5 mg. Inj.